down arrow

Medicure, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA58469E4085
CAD
1.34
0.75 (126.77%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Medicure, Inc.
Devonian Health Group, Inc.
Valeo Pharma, Inc.
Avricore Health, Inc.
Alpha Cognition, Inc.
Helix BioPharma Corp.
Satellos Bioscience, Inc.
Resverlogix Corp.
Aptose Biosciences, Inc.
Sirona Biochem Corp.
Antibe Therapeutics, Inc.
Why is Medicure, Inc. ?
1
Poor Management Efficiency with a low ROE of 0.78%
  • The company has been able to generate a Return on Equity (avg) of 0.78% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 5 consecutive quarters
  • NET PROFIT(9M) At CAD -2.43 MM has Grown at -71.76%
  • RAW MATERIAL COST(Y) Grown by 24.61% (YoY)
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 36.73%, its profits have fallen by -22.1%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medicure, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medicure, Inc.
-100.0%
-0.53
93.56%
S&P/TSX 60
19.1%
1.25
15.27%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.59%
EBIT Growth (5y)
10.58%
EBIT to Interest (avg)
-2.20
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.07
Tax Ratio
17.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
1.01%
ROE (avg)
0.78%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.63
EV to EBIT
-2.40
EV to EBITDA
-7.22
EV to Capital Employed
0.51
EV to Sales
0.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-21.43%
ROE (Latest)
-17.55%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

Higher at CAD -1.25 MM

DEBT-EQUITY RATIO (HY)

Lowest at -31.55 %

DEBTORS TURNOVER RATIO(HY)

Highest at 4.41%

-5What is not working for the Company
NET PROFIT(9M)

At CAD -2.43 MM has Grown at -71.76%

RAW MATERIAL COST(Y)

Grown by 24.61% (YoY

Here's what is working for Medicure, Inc.
Net Profit
Higher at CAD -1.25 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Debt-Equity Ratio
Lowest at -31.55 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 4.41%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Medicure, Inc.
Raw Material Cost
Grown by 24.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."